State Street Corp Amicus Therapeutics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

A detailed history of State Street Corp transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 10,970,746 shares of FOLD stock, worth $106 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,970,746
Previous 11,016,963 0.42%
Holding current value
$106 Million
Previous $109 Million 7.21%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$9.55 - $12.09 $441,372 - $558,763
-46,217 Reduced 0.42%
10,970,746 $117 Million
Q2 2024

Aug 14, 2024
SELL
$9.04 - $11.75 $12.9 Million - $16.8 Million
-1,425,538 Reduced 11.46%
11,016,963 $109 Million
Q1 2024

May 15, 2024
SELL
$11.43 - $14.24 $8.24 Million - $10.3 Million
-720,584 Reduced 5.47%
12,442,501 $147 Million
Q4 2023

Feb 14, 2024
BUY
$9.97 - $14.52 $17.9 Million - $26 Million
1,790,649 Added 15.75%
13,163,085 $187 Million
Q3 2023

Nov 14, 2023
BUY
$11.78 - $13.86 $2.28 Million - $2.68 Million
193,194 Added 1.73%
11,372,436 $138 Million
Q2 2023

Aug 14, 2023
BUY
$10.72 - $13.3 $518,387 - $643,148
48,357 Added 0.43%
11,179,242 $140 Million
Q1 2023

May 15, 2023
SELL
$10.91 - $13.54 $10.4 Million - $12.9 Million
-954,954 Reduced 7.9%
11,130,885 $123 Million
Q4 2022

Feb 14, 2023
BUY
$9.89 - $12.7 $629,271 - $808,062
63,627 Added 0.53%
12,085,839 $148 Million
Q3 2022

Nov 15, 2022
SELL
$9.82 - $12.75 $18.6 Million - $24.2 Million
-1,896,103 Reduced 13.62%
12,022,212 $126 Million
Q2 2022

Aug 15, 2022
BUY
$6.23 - $11.12 $12.4 Million - $22.1 Million
1,983,752 Added 16.62%
13,918,315 $149 Million
Q1 2022

May 16, 2022
BUY
$7.89 - $12.48 $11.3 Million - $17.9 Million
1,432,498 Added 13.64%
11,934,563 $113 Million
Q4 2021

Feb 14, 2022
BUY
$9.82 - $12.44 $4.78 Million - $6.05 Million
486,335 Added 4.86%
10,502,065 $121 Million
Q3 2021

Nov 15, 2021
BUY
$8.74 - $11.84 $5.06 Million - $6.86 Million
579,481 Added 6.14%
10,015,730 $95.7 Million
Q2 2021

Aug 16, 2021
SELL
$8.71 - $10.72 $877,036 - $1.08 Million
-100,693 Reduced 1.06%
9,436,249 $91 Million
Q1 2021

May 17, 2021
BUY
$9.2 - $23.86 $15 Million - $38.8 Million
1,627,551 Added 20.58%
9,536,942 $94.2 Million
Q4 2020

Feb 16, 2021
SELL
$13.47 - $24.89 $13.7 Million - $25.4 Million
-1,019,668 Reduced 11.42%
7,909,391 $183 Million
Q3 2020

Nov 10, 2020
SELL
$12.89 - $15.89 $17.5 Million - $21.5 Million
-1,354,448 Reduced 13.17%
8,929,059 $126 Million
Q2 2020

Aug 14, 2020
SELL
$8.86 - $15.69 $7.49 Million - $13.3 Million
-845,644 Reduced 7.6%
10,283,507 $155 Million
Q1 2020

May 11, 2020
BUY
$6.63 - $11.16 $73.8 Million - $124 Million
11,129,151 New
11,129,151 $103 Million

Others Institutions Holding FOLD

# of Institutions
312
Shares Held
314M
Call Options Held
516K
Put Options Held
833K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.7B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email